Lyme disease: Disparity between culture and polymerase chain reaction detection of Borrelia burgdorferi after exposure to ceftriaxone in vitro

Connecticut Medicine

Volumn 63, Issue 10, 1999, Pages 589-591

  Varde, Shobha ^a   Wormser, Gary P ^a   Nowakowski, John ^a   Nadelman, Robert B ^a   Bittker, Susan ^a   Cooper, Denise ^a   Schwartz, Ira ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CEFTRIAXONE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BORRELIA BURGDORFERI; CELL VIABILITY; CONTROLLED STUDY; DISEASE MARKER; LYME DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION;

BORRELIA BURGDORFERI GROUP; CEFTRIAXONE; CELL SURVIVAL; CELLS, CULTURED; CEPHALOSPORINS; COLONY COUNT, MICROBIAL; DNA, BACTERIAL; HUMANS; LYME DISEASE; MICROSCOPY, FLUORESCENCE; POLYMERASE CHAIN REACTION;

EID: 0032708799     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Steere A: Lyme disease. N Engl J Med 1989; 321:586-96.
2. Steere A: Lyme disease: A growing threat to urban populations. Proc Natl Acad Sci USA 1994; 91:2378-83.
3. Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, et al: Serodiagnosis in early Lyme disease. J Clin Microbiol 1993; 31:3090-5.
4. Schwartz I, Wormser GP, Schwartz JJ, et al: Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol 1992; 30:3082-8.
5. Wormser GP, Nowakowski J. Nadelman RB, et al: Improving the yield of blood cultures for patients with early Lyme disease. J Clin Microbiol 1998; 36:296-8.
6. Schmidt BL: PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Revs 1997; 10:185-201.
7. Malawista SE, Barthold SW, Persing DH: Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment. J Infect Dis 1994; 170:1312-6.
8. Schwartz I, Varde S, Nadelman RB, Wormser GP, Fish D: Inhibition of efficient polymerase chain reaction amplification of Borrelia burgdorferi DNA in blood-fed ticks. Am J Trop Med Hyg 1997; 56:339-42.
9. Moody K, Barthold S, Terwilliger G, et al: Experimental chronic Lyme borreliosis in Lewis Rats. Am J Trop Med Hyg 1990; 42:165-74.
10. Goodman J, Jurkovich P, Kodner C, Johnson R: Persistent cardiac and urinary tract infections with B. burgdorferi in experimentally infected Syrian hamsters. J Clin Microbiol 1991; 29:894-6.
11. Barthold SW, Sidman CL, Smith AL: Lyme borreliosis in genetically resistant and susceptible mice with severe combined immuno-deficiency. Am J Trop Med Hyg 1992; 47:605-13.
12. Pachner AR, Ricalton N, Delaney E: Comparison of polymerase chain reaction with culture and serology for diagnosis of murine experimental Lyme borreliosis. J Clin Microbiol 1993; 31:208-14.
13. Kazragis RJ, Dever LL, Jorgensen JH, Barbour AG: In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites. Antimicrob Ag Chemother 1996; 40:2632-6.
14. Moody KD, Adams RL, Barthold SW: Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice. Antimicrob Ag Chemother 1994; 38:1567-72.
15. Straubinger RK, Summers BA, Chang YF, Appel MJ: Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol 1997; 35:111-6.